101 related articles for article (PubMed ID: 21136375)
1. [Uterine carcinosarcoma in a patient using tamoxifen].
Mbarki C; Jnifen A; Mrad M; Ben Jemaa R; Hsayaoui N; Med Imen H; Oueslati H
Tunis Med; 2010 Dec; 88(12):967-8. PubMed ID: 21136375
[No Abstract] [Full Text] [Related]
2. Synchronous uterine carcinosarcoma and contralateral breast cancer after tamoxifen therapy: a case report.
Shen L; Hong L; Zhang G; Mai R
Int J Clin Exp Pathol; 2014; 7(8):5295-301. PubMed ID: 25197413
[TBL] [Abstract][Full Text] [Related]
3. Drugs can reduce the incidence of breast cancer: now what?
Wozniak TF; Eppes PG; Wilson CT
Del Med J; 1999 Sep; 71(9):387-9. PubMed ID: 10584440
[No Abstract] [Full Text] [Related]
4. Similarity of uterine mucosa changes in patients treated by raloxifen and tamoxifen.
Willèn R; Willèn H; Lindahl B
Anticancer Res; 2002; 22(2B):1121-5. PubMed ID: 12168910
[TBL] [Abstract][Full Text] [Related]
5. The uterine carcinosarcoma - a case report.
Niculescu M; Simionescu C; Novac L; Mogoantă L; Stănescu RM
Rom J Morphol Embryol; 2007; 48(4):431-5. PubMed ID: 18060197
[TBL] [Abstract][Full Text] [Related]
6. [Carcinosarcoma of the uterus. Case report].
Maccioni A; Farci G; Zucca G; Camba G
Pathologica; 1980; 72(1022):847-55. PubMed ID: 7290771
[No Abstract] [Full Text] [Related]
7. Carcinosarcoma of the uterus. Report of a case surviving eleven years.
Falk VS
Wis Med J; 1973 Feb; 72(2):85-8. PubMed ID: 4688535
[No Abstract] [Full Text] [Related]
8. Is there an increase in the incidence of uterine carcinosarcoma in north-east Scotland? A 19 years population-based cohort study.
Gurumurthy M; Lahiri R; Scott N; Miller I; Cruickshank ME; Parkin DE
Scott Med J; 2013 May; 58(2):88-94. PubMed ID: 23728753
[TBL] [Abstract][Full Text] [Related]
9. A reconsideration of tamoxifen use for breast cancer.
Wang PH; Chao HT
Taiwan J Obstet Gynecol; 2007 Jun; 46(2):93-5. PubMed ID: 17638615
[No Abstract] [Full Text] [Related]
10. Tamoxifen infrequently used by women at risk for breast cancer.
Dreyfuss JH
CA Cancer J Clin; 2010; 60(4):204-6. PubMed ID: 20530798
[No Abstract] [Full Text] [Related]
11. Experts hopeful about designer estrogens. For some women, selective estrogen receptor modulators (SERMs) help prevent breast cancer.
Runowicz CD
Health News; 2003 Apr; 9(4):1-2. PubMed ID: 12710388
[No Abstract] [Full Text] [Related]
12. [Tamoxifen in the adjuvant setting for breast cancer: Reflexions about the risk of uterine carcinosarcoma].
Leung F; Terzibachian JJ; Govyadovskiy A; Bourtembourg A; Maillet R; Riethmuller D
Gynecol Obstet Fertil; 2009 May; 37(5):447-51. PubMed ID: 19394886
[TBL] [Abstract][Full Text] [Related]
13. Carcinosarcoma arising in uterine didelphys after tamoxifen therapy for breast cancer: a case report.
Suprasert P; Khunamornpong S
J Med Assoc Thai; 2010 May; 93(5):608-12. PubMed ID: 20524448
[TBL] [Abstract][Full Text] [Related]
14. [Tamoxifen and breast cancer].
Nechushtan H; Peretz T
Harefuah; 2002 Aug; 141(8):718-20, 761, 760. PubMed ID: 12222137
[TBL] [Abstract][Full Text] [Related]
15. Moving forward with breast cancer prevention.
Chen WY; Rosner B; Colditz GA
Cancer; 2007 Jun; 109(12):2387-91. PubMed ID: 17464950
[No Abstract] [Full Text] [Related]
16. Consensus statement outlines adjuvant treatment options for women with breast cancer.
Rollins G
Rep Med Guidel Outcomes Res; 2001 Jan; 12(2):9-10, 12. PubMed ID: 11767779
[No Abstract] [Full Text] [Related]
17. Raloxifene works as well as tamoxifen in preventing invasive breast cancer.
Mayo Clin Womens Healthsource; 2006 Oct; 10(10):3. PubMed ID: 16977270
[No Abstract] [Full Text] [Related]
18. The science of selective estrogen receptor modulators: concept to clinical practice.
Jordan VC
Clin Cancer Res; 2006 Sep; 12(17):5010-3. PubMed ID: 16951214
[No Abstract] [Full Text] [Related]
19. Regression of morphoea plaques after tamoxifen therapy.
Ayoub N; Bouaziz JD; Barete S; Frances C
J Eur Acad Dermatol Venereol; 2004 Sep; 18(5):637-8. PubMed ID: 15324417
[No Abstract] [Full Text] [Related]
20. Tamoxifen for breast cancer prevention.
Breckwoldt M; Karck U
Exp Clin Endocrinol Diabetes; 2000; 108(4):243-6. PubMed ID: 10961352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
